This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Takeda Pharmaceutical Company Limited, Other. Active years: 2004-2007.
Location History:
- Okayama-shi, Okayama, JP (2004)
- Okayama, JP (2007)
Company Filing History:
1 out of 1,226 
1 out of 834,411 Years Active: 2004-2007
Title: Masayoshi Nanba: Innovator in Hepatocyte Research
Introduction
Masayoshi Nanba is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of hepatocyte research, particularly in the development of immortalized liver cell lines. With a total of 2 patents, his work has implications for therapeutic advancements in liver health.
Latest Patents
Nanba's latest patents include a groundbreaking invention titled "Human derived immortalized liver cell line." This invention relates to a new immortalized hepatocyte culture of human normal cell origin, which is particularly useful for screening compounds that may have therapeutic or preventive effects on hepatic insufficiency. Another notable patent is "Human cell line showing stable expression of cytochromes P450." This invention involves cell lines derived from human liver that stably express various human cytochromes P450, aiding in the analysis of enzymes involved in the metabolism of xenobiotics and endogenous substrates.
Career Highlights
Throughout his career, Masayoshi Nanba has worked with esteemed organizations, including Takeda Pharmaceutical Company Limited. His research has been pivotal in advancing the understanding of liver cell biology and its applications in drug development.
Collaborations
Nanba has collaborated with notable colleagues such as Sumie Yoshitomi and Satoru Asahi, contributing to a rich exchange of ideas and innovations in the field.
Conclusion
Masayoshi Nanba's contributions to hepatocyte research and his innovative patents highlight his role as a key figure in the advancement of liver health therapies. His work continues to influence the scientific community and pave the way for future research.